H. Kang

发表

A randomized, double-blind, Phase 1 study of IN-006, an inhaled antibody treatment for COVID-19

T. Moench, M. McSweeney, J. Hutchins, 2022, medRxiv.

[Pharmacotherapeutics for the New Coronavirus Pneumonia].

X. Y. Li, Bin Du, Z. Tong, 2020, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[The keypoints in treatment of the critical novel coronavirus pneumonia patient].

X. Y. Li, Z. Tong, H. Qiu, 2020, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.